Article: A sublingual grass pollen allergy vaccine tablet [Oralair Grasses] has shown positive results in an allergen challenge chamber study

A sublingual grass pollen allergy vaccine tablet [Oralair Grasses] has shown positive results in an allergen challenge chamber study. In the phase I, randomised trial, sublingual immunotherapy was administered to 86 adult patients with grass pollen rhinoconjunctivitis. The outcomes of this trial were: an onset of action starting on day 7, an ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!